20-62330822-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005560.6(LAMA5):​c.3773T>C​(p.Met1258Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.894 in 1,547,168 control chromosomes in the GnomAD database, including 625,037 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.80 ( 50275 hom., cov: 31)
Exomes 𝑓: 0.90 ( 574762 hom. )

Consequence

LAMA5
NM_005560.6 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.296

Publications

28 publications found
Variant links:
Genes affected
LAMA5 (HGNC:6485): (laminin subunit alpha 5) This gene encodes one of the vertebrate laminin alpha chains. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. The protein encoded by this gene is the alpha-5 subunit of of laminin-10 (laminin-511), laminin-11 (laminin-521) and laminin-15 (laminin-523). [provided by RefSeq, Jun 2013]
LAMA5 Gene-Disease associations (from GenCC):
  • nephrotic syndrome, IIa 26
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • LAMA5-related multisystemic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.261096E-7).
BP6
Variant 20-62330822-A-G is Benign according to our data. Variant chr20-62330822-A-G is described in ClinVar as Benign. ClinVar VariationId is 1233173.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.92 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA5NM_005560.6 linkc.3773T>C p.Met1258Thr missense_variant Exon 30 of 80 ENST00000252999.7 NP_005551.3 O15230-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA5ENST00000252999.7 linkc.3773T>C p.Met1258Thr missense_variant Exon 30 of 80 1 NM_005560.6 ENSP00000252999.3 O15230-1

Frequencies

GnomAD3 genomes
AF:
0.796
AC:
120941
AN:
151864
Hom.:
50268
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.534
Gnomad AMI
AF:
0.948
Gnomad AMR
AF:
0.803
Gnomad ASJ
AF:
0.903
Gnomad EAS
AF:
0.942
Gnomad SAS
AF:
0.800
Gnomad FIN
AF:
0.852
Gnomad MID
AF:
0.831
Gnomad NFE
AF:
0.925
Gnomad OTH
AF:
0.840
GnomAD2 exomes
AF:
0.859
AC:
135333
AN:
157512
AF XY:
0.864
show subpopulations
Gnomad AFR exome
AF:
0.518
Gnomad AMR exome
AF:
0.818
Gnomad ASJ exome
AF:
0.896
Gnomad EAS exome
AF:
0.952
Gnomad FIN exome
AF:
0.854
Gnomad NFE exome
AF:
0.925
Gnomad OTH exome
AF:
0.866
GnomAD4 exome
AF:
0.905
AC:
1262294
AN:
1395186
Hom.:
574762
Cov.:
63
AF XY:
0.903
AC XY:
621480
AN XY:
688008
show subpopulations
African (AFR)
AF:
0.513
AC:
16322
AN:
31824
American (AMR)
AF:
0.815
AC:
29169
AN:
35804
Ashkenazi Jewish (ASJ)
AF:
0.899
AC:
22126
AN:
24604
East Asian (EAS)
AF:
0.953
AC:
34372
AN:
36072
South Asian (SAS)
AF:
0.802
AC:
63206
AN:
78802
European-Finnish (FIN)
AF:
0.852
AC:
39278
AN:
46116
Middle Eastern (MID)
AF:
0.850
AC:
4789
AN:
5636
European-Non Finnish (NFE)
AF:
0.929
AC:
1001924
AN:
1078504
Other (OTH)
AF:
0.884
AC:
51108
AN:
57824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
6469
12938
19408
25877
32346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21128
42256
63384
84512
105640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.796
AC:
121000
AN:
151982
Hom.:
50275
Cov.:
31
AF XY:
0.793
AC XY:
58902
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.534
AC:
22134
AN:
41418
American (AMR)
AF:
0.803
AC:
12267
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.903
AC:
3133
AN:
3468
East Asian (EAS)
AF:
0.942
AC:
4813
AN:
5110
South Asian (SAS)
AF:
0.800
AC:
3861
AN:
4828
European-Finnish (FIN)
AF:
0.852
AC:
9021
AN:
10588
Middle Eastern (MID)
AF:
0.825
AC:
241
AN:
292
European-Non Finnish (NFE)
AF:
0.925
AC:
62890
AN:
67972
Other (OTH)
AF:
0.841
AC:
1777
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1027
2053
3080
4106
5133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.876
Hom.:
28623
Bravo
AF:
0.783
TwinsUK
AF:
0.936
AC:
3470
ALSPAC
AF:
0.927
AC:
3571
ESP6500AA
AF:
0.565
AC:
2406
ESP6500EA
AF:
0.929
AC:
7826
ExAC
AF:
0.825
AC:
86413
Asia WGS
AF:
0.837
AC:
2911
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19435634) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
3.3
DANN
Benign
0.29
DEOGEN2
Benign
0.013
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.087
T
MetaRNN
Benign
8.3e-7
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.20
N
PhyloP100
0.30
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
1.1
N
REVEL
Benign
0.037
Sift
Benign
0.45
T
Sift4G
Benign
0.77
T
Polyphen
0.0
B
Vest4
0.029
ClinPred
0.0027
T
GERP RS
1.8
Varity_R
0.021
gMVP
0.26
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3810548; hg19: chr20-60905878; COSMIC: COSV53354046; COSMIC: COSV53354046; API